Answer
Retrophin, the major pharmaceutical company Martin Shkreli co-founded, focuses on developing and commercializing drugs for rare diseases. With a primary emphasis on the field of rare diseases, Retrophin aims to address unmet medical needs and improve the lives of patients affected by these debilitating conditions.